NICE issues second draft guidance on the use of Pixuvri as monotherapy to ... pharmabiz.com The European Medicines Agency's (the EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoing randomized controlled Phase 3 clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have ... |
